ORALLY OR PARENTERALLY ADMINISTRABLE L CARNITINE CONTAINING

Brand Owner (click to sort) Address Description
CARNIA SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Viale Shakespeare, 47 ROMA 00144 Italy ORALLY OR PARENTERALLY ADMINISTRABLE L-CARNITINE-CONTAINING COMPOSITIONS FOR TREATING CARDIAC DISEASES;
CARNICOR SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Viale Shakespeare, 47 ROMA 00144 Italy ORALLY OR PARENTERALLY ADMINISTRABLE L-CARNITINE-CONTAINING COMPOSITIONS FOR TREATING CARDIAC DISEASES;
CARNICOR SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Viale Shakespeare, 47 ROMA 00144 Italy orally or parenterally administrable L-carnitine-containing compositions for treating cardiac diseases;
CARNIDEX SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Viale Shakespeare, 47 ROMA 00144 Italy ORALLY OR PARENTERALLY ADMINISTRABLE L-CARNITINE-CONTAINING COMPOSITIONS FOR TREATING CARDIAC DISEASES;PLASKO LIGHT;
CARNISKEM SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Viale Shakespeare, 47 ROMA 00144 Italy ORALLY OR PARENTERALLY ADMINISTRABLE L-CARNITINE-CONTAINING COMPOSITIONS FOR TREATING CARDIAC DISEASES;
CARNISKEM SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Viale Shakespeare, 47 ROMA 00144 Italy orally or parenterally administrable L-carnitine-containing compositions for treating cardiac diseases;
CARNYDYN SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Viale Shakespeare, 47 ROMA 00144 Italy Orally or Parenterally Administrable L-Carnitine-Containing Compositions for Treating Cardiac Diseases;
CARNYDYN SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Viale Shakespeare, 47 ROMA 00144 Italy orally or parenterally administrable l-carnitine-containing compositions for treating cardiac diseases;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention is directed to parenterally-administrable microparticles for providing sustained-release of a therapeutic agent in the body, where the microparticles include a polymeric core containing a therapeutically effective amount of a therapeutic agent disposed therein, a first film encapsulating the core, the first film prepared from a first biodegradable polymer soluble in an appropriate solvent therefore, and a second film encapsulating the core and the first film, the second film prepared from a biodegradable polymer soluble in an appropriate solvent therefore, wherein the first film is insoluble in the solvent used to prepare the second film, and to parenterally-administrable compositions containing such microparticles dispersed in a suitable carrier therefore.